|
NHLRC2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.37008199124966E-12 |
| Normal-vs-Stage2 |
1.09199982389896E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
2.064000E-01 |
| Stage1-vs-Stage3 |
4.52640000003779E-06 |
| Stage1-vs-Stage4 |
7.66269999999958E-05 |
| Stage2-vs-Stage3 |
6.591600E-02 |
| Stage2-vs-Stage4 |
5.049900E-02 |
| Stage3-vs-Stage4 |
6.945400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62470037423645E-12 |
| Normal-vs-AfricanAmerican |
1.62447832963153E-12 |
| Normal-vs-Asian |
2.414000E-02 |
| Caucasian-vs-AfricanAmerican |
9.382900E-03 |
| Caucasian-vs-Asian |
3.484400E-01 |
| AfricanAmerican-vs-Asian |
3.421800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
1.65756297576536E-12 |
| Male-vs-Female |
8.426300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.32130003896947E-09 |
| Normal-vs-Age(41-60Yrs) |
1.73261405223002E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
1.76000003460075E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.722800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.367600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.132600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.041430E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.446960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.566600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.374300E-02 |
| Normal-vs-Grade 2 |
2.91766610871491E-13 |
| Normal-vs-Grade 3 |
1.62436730732907E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
1.889610E-01 |
| Grade 1-vs-Grade 3 |
3.144400E-02 |
| Grade 1-vs-Grade 4 |
2.972900E-04 |
| Grade 2-vs-Grade 3 |
1.283630E-02 |
| Grade 2-vs-Grade 4 |
4.39999999990448E-07 |
| Grade 3-vs-Grade 4 |
3.440300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.04050007393641E-10 |
| Normal-vs-ccB subtype |
1.62447832963153E-12 |
| ccA subtype-vs-ccB subtype |
5.642100E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63891122895166E-12 |
| Normal-vs-N1 |
4.85419999751713E-08 |
| N0-vs-N1 |
1.139200E-01 |
|
|
